Aim. To develop diagnostic assays, based on the amplification refractory mutation system (ARMS) principle, for detection of common mutations in the CFTR
Introduction. Cystic fibrosis (CF) is one of the most common autosomal-recessive disorders in Caucasians that occurs with the frequency of 1/2500 newborns and is caused by mutations in the CFTR gene. More than 1700 mutations were identified in this gene and the dF508 deletion was described as a causative mutation [1, 2] . A number of methods are applied for molecular genetic diagnostics of CF, namely, RFLP, SSCP, DGGE, dHPLC etc., but they are relatively slow and technically demanding.
Several independent groups described a PCR-based approach for analyzing known point mutations in DNA and distinguishing between the normal, heterozygous and homozygous mutant genotypes. This method is commonly referred to as PCR-ARMS or ARMS (amplification refractory mutation system). ARMS is based on the observation that PCR amplification is inefficient or completely refractory if there is a mismatch between the 3' terminal nucleotide of a PCR primer and a corresponding template [3] [4] [5] .
This approach implies two PCR reactions. Amplification of the normal allele is accomplished using a primer complementary to the normal allele. Conversely, only the mutant allele will be amplified if the 3' residue is complementary to the mutant sequence. Thus, as a result a normal individual generates PCR product only in the normal reaction; a heterozygote gives products in both reactions, and a homozygous mutant individual gives amplification only in the mutant reaction [6] .
This method has many advantages over the traditional methods of mutation detection: it is rapid (the analysis is done in 2-3 hours), inexpensive, reliable when a positive control sample is used, and it can be easily visualized not only by electrophoresis in agarose gel but also by means of Real-Time PCR system. However, the ARMS method depends on several factors: proper primers design and optimization of PCR conditions to avoid nonspecific amplification of the normal/mutant allele that could bring to false positive or negative results [6, 7] .
Our aim was to develop ARMS methods for the analysis of common mutations causing CF, using both general PCR with the agarose gel electrophoresis system and Real-Time PCR assay as a prototype of the test kits for molecular genetic diagnostics of CF. For our study we have chosen the following mutations: dF508, W1282X, R117H, 621 + 1G > T, 2143delT. We have calculated the frequencies of these mutations in Ukraine as dF508 -43.3 %; 2143delT -1.38 %; W1282X -1.1 %; R117H, 621 + G > T -< 0,6 %.
Materials and methods. DNA extraction. DNA was extracted from peripheral blood leukocytes by standard phenol-chloroform extraction methods [9] .
ARMS primers and conditions. ARMS PCR amplification of the dF508, W1282X, R117H, 621 + 1G > T and 2143delT mutations was performed with using specific oligonucleotide primers complementary either to the wild type sequence, or the DNA with mutation (Table) .
The PCR reaction was performed in a final volume of 15 µl containing 1 ´ PCR buffer, 1. GAGACCTTACACCGTTTCTCATTA -wild type
GAGACCTTACACCGTTTCTCATAG -mutant

Sequences of primers for ARMS tests
were previously analyzed using RFLP and a heteroduplex assay [8, [10] [11] [12] [13] .
Results and discussion. To optimize the PCR conditions to avoid non-specific amplification of the alleles we have chosen appropriate concentrations of primers and annealing temperature. Annealing temperature was determined using the gradient PCR (data not shown); the temperature was: for dF508 -59 °C; for 2143delT -64 °C and for the mutations R117H, 621 + 1 G > T, W1282X -67 °C.
It has been shown that the titrating of the concentrations of primers and/or Mg 2+ can improve the specificity of the assay [6, 7] . In Fig. 1 Amplification of the normal samples with the concentration of primers 5 mM can lead to the formation of the PCR product with the mutant pair of primers, while the reduction of concentration to 2.5 mM prevents from nonspecific amplification.
The influence of the primers concentration on the ARMS specificity is more significant when using RealTime PCR. In Fig. 2 the same experiment for the R117H mutation is shown.
We have determined the optimal primers concentrations for the developed assay: dF508 -6 pM of each primer; R117H -2.5 pM of each primer; W1282X, 621 + 1 G > T, 2143delT -10 pM of each primer. The results of detection of the dF508 deletion using standard PCR with further agarose gel electrophoresis of the amplified products and Real-Time PCR assay are presented in Fig. 3 and Fig. 4 correspondently.
Considering the optimized annealing temperatures and primers concentrations, the following amplification conditions for detection assays of the dF508, R117H, 621 + 1 G > T, W1282X, 2143delT mutations were proposed:
-concentration of each primer: dF508 -6 pM; R117H -2.5 pM; W1282X, 621 + 1 G > T, 2143delT -10 pM.
-the cycling conditions for the dF508 mutation were: initial denaturation at 95 °C for 5 min, 30 cycles consisting of denaturation at 95 °C for 30 s, annealing at 59 °C for 30 s, extension at 72 °C for 30 s and a final elongation step at 72 °C for 3 min.
-the cycling conditions for the 2143dT mutation were: initial denaturation at 95 °C for 5 min, 30 cycles consisting of denaturation at 95 °C for 30 s, annealing at 64 °C for 30 s, extension at 72 °C for 30 s and a final elongation step at 72 °C for 3 min.
-the cycling conditions for the R117H, 621 + 1 G > T, W1282X mutations were: initial denaturation at 95 o C for 5 min, 30 cycles consisting of denaturation at 95 °C for 30 s, annealing at 66 °C for 30 s, extension at 72 °C for 30 s, and a final elongation step at 72 °C for 3 min.
-in case of the Real-Time PCR procedure, the cycling conditions were as follows: initial denaturation at 95 °C for 10 min, 35 two-step cycles consisting of denaturation at 95 °C for 20 s and annealing with elongation at 57 °C (for dF508), 64 °C (for 2143dT) and 67 °C (R117H, 621 + 1 G > T, W1282X) for 30 s.
To validate the method developed we have analyzed the control DNA samples with the W1282X (n = 3), R117H (n = 2), 621 + 1G > T (n = 1), 2143delT (n = 1) mutations. For validation of the dF508 ARMS test we have analyzed 100 heterozygous carriers and 50 homozygous carriers of the dF508 mutation. No differences were observed in the results obtained using the standard protocols, except for one control DNA sample with heterozygous dF508 mutation, which as a result of the detailed analysis using the standard sequenced control sample, appeared to be the dI507 mutation, that proves the effectiveness of the developed assay.
For the analysis of 2143delT mutation we have used the heteroduplex assay to identify the mutant profile for further detection of this deletion with ARMS PCR (Fig. 5) [12, 13] . Using the heteroduplex analysis of the exon 13 CFTR gene we have identified the 2143delT and 2184insA mutations in the control DNA samples. However, application of the heteroduplex analysis for detection of the single-nucleotide deletions/insertions is restricted because of impossibility to detect the mutant homozygote; therefore the ARMS test is preferable.
We have analyzed 48 CF patients, in which one mutation was previously detected, using the developed ARMS assay for the 2143delT mutation and detected 4 heterozygous carriers. The 2184insA mutation was identified in 12 CF patients using the heteroduplex analysis.
Conclusions. We have developed and, using the analysis of the control DNA samples, validated the diagnostic assays for the detection of common CF mutations: dF508, R117H, 621 + 1G > T, W1282X and 2143delT with the ARMS PCR approach. It was shown that the ARMS is a reliable, rapid and inexpensive method and the developed assays can be applied in the standard PCR protocol with further gel-electrophoresis as well as Real-Time PCR with SYBR Green.
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